Treatment of high-risk T-NHL with autologous or allogeneic stem cell transplantation

被引：0
|
作者：
Busemann, C. [1 ]
Klein, S. [1 ]
Schmidt, C. A. [1 ]
Evert, M. [1 ]
Doelken, G. [1 ]
Krueger, W. H. [1 ]
机构：
[1] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S542 / S543
页数：2
相关论文
共 50 条
  • [31] BEAM-alemtuzumab followed by allogeneic SCT for the treatment of relapsed or refractory T-NHL
    Repp, R.
    Guenther, A.
    Schade, H.
    Humpe, A.
    Gahn, B.
    Nickelsen, M.
    Claviez, A.
    Schrauder, A.
    Gramatzki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Autologous stem cell transplantation (ASCT) for high-risk pediatric solid tumors
    Fraser, VJ
    Weigel, BJ
    John, PP
    Todd, DE
    Kevin, BS
    Michael, VR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 65 - 65
  • [33] Clinical Features and Treatment Results of Children with High-Risk Neuroblastoma Undergone to Autologous Stem Cell Transplantation
    Atas, Erman
    Kutluk, M. Tezer
    Akyuz, Canan
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2018, 28 (03): : 187 - 196
  • [34] Allogeneic hematopoietic stem cell transplantation in the treatment of very high-risk acute leukemia in children.
    Stary, J
    Kobylka, P
    Sedlacek, P
    Komrska, V
    Vavra, V
    Syruckova, Z
    Smisek, P
    Hruba, A
    Korinkova, P
    Matejkova, E
    Cukrova, V
    Dolezalova, L
    Loudova, M
    Sejkorova, J
    Kvech, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S1 - S1
  • [35] Identifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation
    Bai, Bing
    Gao, Yan
    Wang, Xiao-Xiao
    He, Hai-Xia
    Ping, Li-Qin
    Li, Peng-Fei
    Huang, Cheng
    Cai, Qi-Chun
    Huang, Hui-Qiang
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3404 - 3411
  • [36] Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL
    Bachy, Emmanuel
    Salles, Gilles
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (02) : 257 - 270
  • [37] Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent and Adult Patients with High-Risk T Cell Acute Lymphoblastic Leukemia
    Bakr, Mohammad
    Rasheed, Walid
    Mohamed, Said Y.
    Al-Mohareb, Fahad
    Chaudhri, Naeem
    Al-Sharif, Fahad
    Al-Zahrani, Hazza
    Al-Dawsari, Ghuzayel
    Saleh, Abu Jafar
    Nassar, Amr
    Ahmed, Shad
    Elghazaly, Assem
    Ahmed, Syed O.
    Ibrahim, Khalid
    Chebbo, Wahiba
    El Gohary, Ghada M.
    Al Mahayni, Muhamad H.
    Hussain, Fazal
    Nurgat, Zubeir
    Elhassan, Tusneem Ahmed
    Walter, Claudia U.
    Aljurf, Mahmoud
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1897 - 1904
  • [38] Dose escalated CHOP plus etoposide with repetitive autologous stem cell transplantation as primary treatment for aggressive T-NHL: results of three consecutive phase I/II trials
    Nickelsen, M
    Kloess, M
    Loeffler, M
    Glass, B
    Truemper, L
    Pfreundschuh, M
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S28 - S28
  • [39] Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Becker, Pamela S.
    Fang, Min
    Martin, Paul J.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco
    BLOOD ADVANCES, 2017, 1 (24) : 2247 - 2256
  • [40] AUTOLOGOUS OR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK AGGRESSIVE LYMPHOMAS: RETROSPECTIVE ANALYSIS IN A SINGLE CENTER IN KOREA
    Yoon, J. H.
    Jeon, Y. W.
    Kim, J. H.
    Shin, S. H.
    Lee, S. E.
    Eom, K. S.
    Kim, Y. J.
    Lee, S.
    Kim, H. J.
    Min, C. K.
    Kim, D. W.
    Lee, J. W.
    Min, W. S.
    Park, C. W.
    Cho, S. G.
    HAEMATOLOGICA, 2014, 99 : 422 - 423
12345